White Christopher R H, Doherty Dorota A, Henderson Jennifer J, Kohan Rolland, Newnham John P, Pennell Craig E
School of Women’s and Infants’ Health, The University of Western Australia.
J Matern Fetal Neonatal Med. 2012 Sep;25(9):1653-9. doi: 10.3109/14767058.2011.653421. Epub 2012 Apr 3.
Hypoxic-ischaemic encephalopathy (HIE) is a major acute neurologic manifestation of perinatal asphyxia associated with significant mortality and morbidity. The study aimed to develop a simple, accurate method of predicting HIE at delivery.
Between January 2003 and December 2009, all HIE cases were identified from the 38,404 deliveries at a single tertiary centre. Receiver operating curve (ROC) analysis and multivariate logistic regression assessed the ability of clinical and biochemical assessments to predict HIE.
Sixty neonates met the HIE criteria: 39 were moderate-severe HIE. Univariate analyses identified clinical neonatal markers (Apgar scores and neonatal resuscitation level) to be better HIE predictors than biochemical markers (umbilical artery pH, base excess and lactate values). Multivariable models using two to four predictors had areas under ROC curves up to 0.98, sensitivities up to 93% and specificities up to 99%. For moderate-severe HIE, the most effective predictor was neonatal resuscitation level and arterial lactate (ROC 0.98, sensitivity 85%, specificity 99%).
The combination of umbilical arterial lactate and neonatal resuscitation level provides a rapid and accurate method of predicting moderate-severe HIE that can identify neonates at birth that may benefit from tertiary care and neuroprotective therapies.
缺氧缺血性脑病(HIE)是围产期窒息的一种主要急性神经表现,与显著的死亡率和发病率相关。本研究旨在开发一种在分娩时预测HIE的简单、准确方法。
在2003年1月至2009年12月期间,从一个单一的三级中心的38404例分娩中识别出所有HIE病例。通过受试者操作特征曲线(ROC)分析和多变量逻辑回归评估临床和生化评估预测HIE的能力。
60例新生儿符合HIE标准:39例为中重度HIE。单因素分析表明,临床新生儿指标(阿氏评分和新生儿复苏水平)比生化指标(脐动脉pH值、碱剩余和乳酸值)更能预测HIE。使用两到四个预测指标的多变量模型的ROC曲线下面积高达0.98,敏感度高达93%,特异度高达99%。对于中重度HIE,最有效的预测指标是新生儿复苏水平和动脉乳酸(ROC 0.98,敏感度85%,特异度99%)。
脐动脉乳酸和新生儿复苏水平的联合提供了一种快速、准确的预测中重度HIE的方法,该方法可以在出生时识别可能从三级护理和神经保护治疗中受益的新生儿。